Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Tags:
Mental health

Recovery Record - Eating Disorder Management

  • Analysis

Recovery Record is the smart companion for managing the journey to recovery from eating disorders, including anorexia nervosa, bulimia nervosa and binge eating disorder

Site name: Recovery Record - Eating Disorder Management

Description: 

Recovery Record is the smart companion for managing the journey to recovery from eating disorders, including anorexia nervosa, bulimia nervosa and binge eating disorder.

This app is also intended for people with general eating, weight and shape concerns.

For: iPhone, iPad, iPad touch and Android
Table

View full table

Topics

         
Pharmacist
York, North Yorkshire
£53,025

Apply Now
Tags:
Mental health
Latest News & Analysis

Superdrug announces plans to open 25 new stores this year

NPA delivers £108m invoice to DH as Sunak says he ‘cares deeply’ about sector

OTCs could be ‘profit rockets’ for pharmacies, says Maxwellia boss

Menopause? Meet the award-winning private pharmacy throwing menopausal women a lifeline

See All
UsernamePublicRestriction

Register

CD004222

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By